Tapering antipsychotic medication: practical considerations
Psychol Med
.
2022 Jan;52(1):32-35.
doi: 10.1017/S0033291721003299.
Epub 2021 Sep 20.
Authors
Mark A Horowitz
1
2
,
Joanna Moncrieff
1
2
,
Lieuwe de Haan
3
,
Jan P A M Bogers
4
,
Shiral S Gangadin
5
,
Martijn Kikkert
6
,
Wim Veling
7
,
Iris E C Sommer
5
7
Affiliations
1
Department of Psychiatry, University College London, London, UK.
2
Goodmayes Hospital, North East London NHS Foundation Trust, London, UK.
3
Amsterdam UMC, location AMC/Arkin, Amsterdam, Netherlands.
4
Mental Health Organisation Rivierduinen, High Care Clinics, Leiden, The Netherlands.
5
Department of Biomedical Sciences of Cells and Systems, Rijksuniversiteit Groningen, University Medical Center Groningen, Groningen, Netherlands.
6
Research Department, Arkin, Amsterdam, Netherlands.
7
Department of Psychiatry, Rijksuniversiteit Groningen, University Medical Center Groningen, Groningen, Netherlands.
PMID:
34542027
DOI:
10.1017/S0033291721003299
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Antipsychotic Agents*
Humans
Substances
Antipsychotic Agents